Cooper, Z. A., Reuben, A., Amaria, R. N., & Wargo, J. A. (2014). Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma. OncoImmunology, 3(9), N.PAG. https://doi.org/10.4161/21624011.2014.954956
Chicago Style (17th ed.) CitationCooper, Zachary A., Alexandre Reuben, Rodabe N. Amaria, and Jennifer A. Wargo. "Evidence of Synergy with Combined BRAF-targeted Therapy and Immune Checkpoint Blockade for Metastatic Melanoma." OncoImmunology 3, no. 9 (2014): N.PAG. https://doi.org/10.4161/21624011.2014.954956.
MLA (9th ed.) CitationCooper, Zachary A., et al. "Evidence of Synergy with Combined BRAF-targeted Therapy and Immune Checkpoint Blockade for Metastatic Melanoma." OncoImmunology, vol. 3, no. 9, 2014, p. N.PAG, https://doi.org/10.4161/21624011.2014.954956.